Clinical features | β-value | Hazard ratio | Confidence interval (95%) | p value |
---|---|---|---|---|
Gender | 0.028 | 1.028 | 0.656–1.612 | 0.904 |
Age ≥ 60 years | 1.289 | 3.628 | 2.208–5.960 | < 0.001 |
Mechanical ventilation | 0.778 | 2.176 | 1.386–3.419 | 0.001 |
Comorbidities | 0.101 | 1.106 | 0.507–2.414 | 0.801 |
Comorbidities (≥ 2) | 0.605 | 1.832 | 1.003–3.346 | 0.049 |
Heparin (no use) | 1.282 | 3.606 | 1.632–7.966 | 0.002 |
Deep Venous thromboembolism | 0.015 | 1.015 | 0.141–7.328 | 0.988 |
Pulmonary involvement > 50% | 0.263 | 1.301 | 0.704–2.404 | 0.400 |
Hydroxychloroquine use | 0.073 | 1.076 | 0.669–1.730 | 0.762 |
Asymptomatic | − 0.427 | 0.652 | 0.262–1.623 | 0.358 |
Gastrointestinal symptoms | 0.796 | 2.217 | 0.893–5.507 | 0.086 |
Cardiovascular disease | 0.563 | 1.757 | 0.871–3.544 | 0.116 |
Liver Disease | 1.143 | 3.137 | 0.755–13.042 | 0.116 |
Chronic kidney disease | 0.473 | 1.605 | 0.822–3.135 | 0.166 |
Asthma | − 3.058 | 0.047 | 0.001–19.973 | 0.322 |
COPD | 0.349 | 1.418 | 0.444–4.530 | 0.556 |
Smoking | 0.458 | 1.581 | 0.577–4.335 | 0.373 |
Diabetes | − 0.011 | 0.989 | 0.627–1.560 | 0.962 |
Obesity | 0.061 | 1.063 | 0.618–1.826 | 0.826 |
Systemic arterial hypertension | 0.447 | 1.564 | 0.992–2.466 | 0.054 |
Cancer | 0.367 | 1.443 | 0.848–2.458 | 0.177 |
Oseltamivir | 0.280 | 1.323 | 0.767–2.283 | 0.314 |
Corticosteroids | − 0.268 | 0.765 | 0.399–1.465 | 0.419 |
Azithromycin | 0.125 | 1.133 | 0.596–2.156 | 0.703 |
Intensive Care Unit (ICU) | 2.103 | 8.194 | 2.001–33.553 | 0.003 |